Pages that link to "Q34596601"
Jump to navigation
Jump to search
The following pages link to K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking (Q34596601):
Displaying 33 items.
- Genetic mutations associated with cigarette smoking in pancreatic cancer (Q24658185) (← links)
- Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer (Q26739706) (← links)
- "Liquid biopsy"-ctDNA detection with great potential and challenges (Q26779222) (← links)
- Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer (Q26785691) (← links)
- Early diagnosis of pancreatic cancer: challenges and new developments (Q27014027) (← links)
- Methylation of cell-free circulating DNA in the diagnosis of cancer (Q28085699) (← links)
- Circulating Tumor DNA as Biomarkers for Cancer Detection (Q33632125) (← links)
- SERPINB5 and AKAP12-- Expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma (Q33715802) (← links)
- Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer (Q33820209) (← links)
- Liquid biopsy: monitoring cancer-genetics in the blood (Q34356149) (← links)
- Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma (Q34747033) (← links)
- Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology (Q35543094) (← links)
- DNA methylation based biomarkers in non-invasive cancer screening (Q36095878) (← links)
- Advances in biomarker research for pancreatic cancer (Q36126609) (← links)
- Epithelial ovarian cancer subtypes attributable to smoking in the Norwegian Women and Cancer Study, 2012 (Q36797302) (← links)
- Methylated DNA and microRNA in body fluids as biomarkers for cancer detection. (Q36913739) (← links)
- Epigenetics and epigenetic alterations in pancreatic cancer. (Q37041763) (← links)
- Genomic and proteomic biomarkers for cancer: a multitude of opportunities. (Q37363928) (← links)
- Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300 000 Norwegian women (Q37592890) (← links)
- KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control (Q37694710) (← links)
- Variation in KRAS driver substitution distributions between tumor types is determined by both mutation and natural selection. (Q38594037) (← links)
- Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer (Q39305196) (← links)
- K-RAS mutation in the screening, prognosis and treatment of cancer (Q39872545) (← links)
- Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides (Q39942125) (← links)
- Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma (Q41766645) (← links)
- ppENK Gene Methylation Status in the Development of Pancreatic Carcinoma (Q41790724) (← links)
- Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging (Q48149907) (← links)
- The signature of liver cancer in immune cells DNA methylation. (Q48155719) (← links)
- Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective. (Q48521971) (← links)
- Targeting the duality of cancer. (Q52539731) (← links)
- Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes. (Q52595056) (← links)
- Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA (Q93056726) (← links)
- Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer (Q103038645) (← links)